Cisco's Q4 Preview Reinforces AI Demand, but the WAIT Rating Holds as Valuation Leaves No Room for Error

What happened

Cisco Systems is set to report Q4 FY2026 results on August 12, with UBS pointing to continued AI infrastructure strength and expecting revenue and earnings above consensus, echoing the company's own raised outlook from last quarter. The DeepValue master report maintains a WAIT rating at $117.5, arguing that the stock's 38.9x P/E and 31.7x EV/EBITDA already discount sustained AI networking demand and successful software platform conversion that have yet to materialize in reported growth. While hyperscaler AI order momentum has been impressive—totaling $9B expected for FY26—the concentration risk remains stark, with product orders up 35% year-over-year but only 19% excluding hyperscalers, highlighting the lumpy, sporadic nature of cloud spending. The upcoming report needs to validate the orders-to-revenue bridge, with management expected to reaffirm at least $6B in FY27 hyperscale AI revenue, while also demonstrating that non-hyperscaler demand is broadening and that the Security and Observability segments can finally shake off Splunk-related headwinds to show accelerating growth. Without these confirmations, the elevated multiple leaves little cushion for disappointment, especially as the restructuring plan reaffirms that cost savings won’t be material, keeping margin pressure in focus.

Implication

Investors should treat Cisco as a show-me story: the next two quarterly reports must prove that hyperscaler AI orders convert into contracted backlog (RPO acceleration), that demand diversifies beyond the hyperscale cloud, and that Security and Observability segments re-accelerate. Until then, the stock is priced for perfection, and entry at $117.5 offers poor risk/reward. Catalysts for a re-rating higher include consistent >30% non-hyperscaler order growth and RPO growth above 8%, but absent those, the WAIT rating and attractive entry zone around $100 provide a better margin of safety.

Thesis delta

The new article reinforces the existing AI infrastructure strength narrative without introducing new data that would alter the investment thesis. The core concerns—valuation, concentration risk, and lack of software recurring growth conversion—remain unchanged. Therefore, the thesis delta is stable, and the WAIT rating stays in place.